Co-delivery of Doxorubicin and Afatinib with pH-responsive Polymeric Nanovesicle for Enhanced Lung Cancer Therapy

Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy

(2018) Yuanyuan Liu et al.   Acta Biomaterialia

Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model

(2018) Weitong Sun et al.   BIOMACROMOLECULES

Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates

(2018) Hadeer M. Abdelaziz et al.   JOURNAL OF CONTROLLED RELEASE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy

(2018) Zhicheng Le et al.   ACS Applied Materials & Interfaces

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

(2017) Christian Manegold et al.   Journal of Thoracic Oncology

“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy

(2016) Jessica A. Kemp et al.   ADVANCED DRUG DELIVERY REVIEWS

Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer

(2016) D.A. Fennell et al.   CANCER TREATMENT REVIEWS

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

(2016) Nazila Kamaly et al.   CHEMICAL REVIEWS

Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy

(2016) Yongju He et al.   JOURNAL OF CONTROLLED RELEASE

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

(2016) Martin Schuler et al.   Journal of Thoracic Oncology

Co-delivery of doxorubicin and arsenite with reduction and pH dual-sensitive vesicle for synergistic cancer therapy

(2016) Lu Zhang et al.   Nanoscale

The Smart Drug Delivery System and Its Clinical Potential

(2016) Dong Liu et al.   Theranostics

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

(2015) Liqiong Cai et al.   BIOMATERIALS

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

(2015) T. Mok et al.   CLINICAL CANCER RESEARCH

Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery

(2015) Donato Cosco et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Double emulsion solvent evaporation techniques used for drug encapsulation

(2015) Muhammad Iqbal et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Synthesis and Characterization of pH-Responsive Copolypeptides Vesicles for siRNA and Chemotherapeutic Drug Co-Delivery

(2015) Zhanrong Li et al.   MACROMOLECULAR BIOSCIENCE

Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles

(2015) Ting Zhang et al.   NANOTECHNOLOGY

Cancer nanomedicine: from targeted delivery to combination therapy

(2015) Xiaoyang Xu et al.   TRENDS IN MOLECULAR MEDICINE

Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application

(2015) Paolo Maione et al.   Therapeutic Advances in Medical Oncology

Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California Cancer Registry analysis

(2014) Matthew S. Lara et al.   LUNG CANCER

Role of integrated cancer nanomedicine in overcoming drug resistance

(2013) Arun K. Iyer et al.   ADVANCED DRUG DELIVERY REVIEWS

Reduction and pH dual-sensitive core-crosslinked polypeptide micelles for triggered doxorubicin release

(2013) Liangliang Wu et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

(2012) Che-Ming Jack Hu et al.   BIOCHEMICAL PHARMACOLOGY

Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks

(2012) Michael J. Lee et al.   CELL

Interlayer-Crosslinked Micelle with Partially Hydrated Core Showing Reduction and pH Dual Sensitivity for Pinpointed Intracellular Drug Release

(2011) Jian Dai et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies

(2011) Beate Pesch et al.   INTERNATIONAL JOURNAL OF CANCER